ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck Hands Over Chinese Partnership

by Ann M. Thayer
February 16, 2015 | APPEARED IN VOLUME 93, ISSUE 7

Merck & Co. and its Chinese partner Simcere Pharmaceutical are restructuring their joint venture in China. The two companies set the venture up in 2011 with an initial focus on branded drugs for cardiovascular and metabolic diseases. Simcere is taking over management of the venture, which will shift its focus to local innovative and mature products.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment